Recommendations for the Clinical Development of Medicinal Products for Non-specific Influenza Chemoprophylaxis
INTRODUCTION. The evolution of the influenza virus has led to a gradual decrease in the effectiveness of current antivirals. Better methods of prevention, detection, control, and treatment of influenza are needed, including more effective vaccines and antivirals. At the moment, the Russian Federatio...
Saved in:
| Main Authors: | A. I. Gubenko, O. Yu. Ivanova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
2024-04-01
|
| Series: | Регуляторные исследования и экспертиза лекарственных средств |
| Subjects: | |
| Online Access: | https://www.vedomostincesmp.ru/jour/article/view/581 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recommendations for the programme of clinical trials of medicinal products for the treatment of influenza
by: A. I. Gubenko, et al.
Published: (2023-12-01) -
Study of the Protective Activity of Thymogen® Dosed Nasal Spray on a Model of Experimental Influenza Pneumonia in Laboratory Animals
by: V. V. Zarubaev, et al.
Published: (2024-01-01) -
Comparison of azithromycin vs doxycycline prophylaxis in leptospirosis, A randomized double blind placebo-controlled trial
by: Ahmad Alikhani, et al.
Published: (2018-11-01) -
Meta-analysis of randomized clinical trials of Riamilovir efficacy in etiotropic therapy of influenza
by: A. U. Sabitov, et al.
Published: (2021-08-01) -
SPECIFIC ASPECTS OF BENEFIT-RISK EVALUATION OF HERBAL MEDICINAL PRODUCTS: ANALYSIS OF REGISTRATION DOSSIERS
by: N. G. Olenina, et al.
Published: (2018-06-01)